ARTICLE | Distillery Therapeutics
CRISPR-Cas9 deletion of mutant APP to treat Alzheimer’s
August 27, 2021 8:26 PM UTC
DISEASE CATEGORY: Neurology
INDICATION: Alzheimer’s disease (AD)...
BCIQ Company Profiles
BCIQ Target Profiles
Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
DISEASE CATEGORY: Neurology
INDICATION: Alzheimer’s disease (AD)...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles